Carestream Molecular Imaging is pleased to sponsor a complementary seminar on Cutting-Edge Imaging Technologies & Strategies in Pre-Clinical Small Animal Research on Tuesday, December 6, in Cambridge, MA.
Ovarian cancer is the fourth-leading cause of cancer-related deaths and the leading cause of gynecological cancer deaths. Recurrence and chemoresistance are the major hurdles in the management of patients with ovarian cancer. Ovarian cancer stem cells (OvCSC) have been postulated as the potential source of recurrence and chemoresistance. Persistence of chemoresistant OvCSCs after debulking or chemotherapy may “heal” the cancer and lead to recurrence.
